Literature DB >> 3680577

Gentamicin disposition in young and elderly patients with various degrees of renal function.

G R Matzke1, J J Jameson, C E Halstenson.   

Abstract

The effect of aging on the total body clearance, volume of distribution, and half-life of gentamicin was examined in 99 febrile patients with various degrees of renal function. In the 50 patients who were 18 to 64 years old, clearance of gentamicin was 79.0 +/- 27.0 mL/min (mean +/- standard deviation), creatinine clearance was 98.6 +/- 33.3 mL/min, volume of distribution was 0.242 +/- 0.077 L/kg, and half-life was 2.63 +/- 0.90 hours. In the 49 patients who were 65 to 90 years old, these values were 36.9 +/- 16.3 mL/min, 51.2 +/- 21.2 mL/min, 0.244 +/- 0.102 L/kg, and 5.80 +/- 4.13 hours. Significant differences were observed between the two groups for all parameters except volume of distribution. Linear regression revealed good correlations between the disposition characteristics (clearance and elimination-rate constant) of gentamicin and age as well as creatinine clearance. However, there was no apparent relationship between the ratio of gentamicin clearance to creatinine clearance and age (r = .0731). These findings suggest that the disposition of gentamicin is independent of age but dependent on renal function.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680577     DOI: 10.1002/j.1552-4604.1987.tb02188.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

1.  Effects of age and gender on pharmacokinetics of cefepime.

Authors:  R H Barbhaiya; C A Knupp; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosides.

Authors:  D Czock; M Giehl; F Keller
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

Review 3.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 4.  Principles of antibiotic prescribing in the elderly.

Authors:  F Borrego; R Gleckman
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

Review 5.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

Review 6.  Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.

Authors:  E Triggs; B Charles
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage.

Authors:  B R Meyers; P Wilkinson
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

Review 8.  Aminoglycosides in the Intensive Care Unit: What Is New in Population PK Modeling?

Authors:  Alexandre Duong; Chantale Simard; Yi Le Wang; David Williamson; Amélie Marsot
Journal:  Antibiotics (Basel)       Date:  2021-04-29

9.  Predictive performance of gentamicin dosing nomograms.

Authors:  Jieon Lee; Seonghae Yoon; Donghoon Shin; HyeKyung Han; Hyungmi An; Jongtae Lee; Kyoung Soo Lim; Kyung-Sang Yu; Howard Lee
Journal:  Drug Des Devel Ther       Date:  2014-08-16       Impact factor: 4.162

10.  A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients.

Authors:  Cornelis Smit; Roeland E Wasmann; Sebastiaan C Goulooze; Eric J Hazebroek; Eric P A Van Dongen; Desiree M T Burgers; Johan W Mouton; Roger J M Brüggemann; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2019-10       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.